| Heidi R Hubbard, MD | |
|
1875 Woodwinds Dr, Woodbury, MN 55125-2298 | |
| (651) 232-6700 | |
| (651) 232-6711 |
| Full Name | Heidi R Hubbard |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1875 Woodwinds Dr, Woodbury, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427012848 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 38530 (Minnesota) | Primary |
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition.
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children's Research Hospital scientists have created the world's largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heidi R Hubbard, MD 1875 Woodwinds Dr, Woodbury, MN 55125-2298 Ph: (651) 232-6700 | Heidi R Hubbard, MD 1875 Woodwinds Dr, Woodbury, MN 55125-2298 Ph: (651) 232-6700 |
News Archive
For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition.
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children's Research Hospital scientists have created the world's largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
› Verified 6 days ago
Dr. Bridgette Marie Suri, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8450 Seasons Pkwy, Woodbury, MN 55125 Phone: 651-702-5300 | |
Alicia Marie Osterman Kemp, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8450 Seasons Pkwy, Woodbury, MN 55125 Phone: 651-702-5300 Fax: 651-702-5305 | |
Michele L Peterson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1875 Woodwinds Dr, Woodbury, MN 55125 Phone: 651-232-6700 Fax: 651-232-6711 | |
Chelsey Prall, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 8450 Seasons Pkwy, Woodbury, MN 55125 Phone: 651-702-5300 Fax: 651-702-5305 | |
Sara K Sweetser, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7803 Afton Rd, Woodbury, MN 55125 Phone: 651-738-0470 Fax: 651-738-8915 | |
Dr. Jennifer M.h. Mccormack, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8450 Seasons Parkway, Healthpartners Woodbury Clinic Ms 32900a, Woodbury, MN 55125 Phone: 651-702-5300 Fax: 651-702-5305 | |
Margaret Kelly Tierney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9680 Tamarack Rd Ste 100, Woodbury, MN 55125 Phone: 651-738-0470 |